Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice

被引:45
|
作者
Berbee, Jimmy F. P. [1 ,2 ]
Wong, Man C. [1 ,3 ]
Wang, Yanan [1 ]
van der Hoorn, Jose W. A. [4 ]
Khedoe, Padmini P. S. J. [1 ,3 ]
van Klinken, Jan B. [5 ]
Mol, Isabel M. [1 ]
Hiemstra, Pieter S. [3 ]
Tsikas, Dimitrios [6 ]
Romijn, Johannes A. [1 ]
Havekes, Louis M. [1 ,4 ,7 ]
Princen, Hans M. G. [4 ]
Rensen, Patrick C. N. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Gen Internal Med Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands
[2] Sanquin Res Amsterdam, Dept Expt Immunohematol, Amsterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Pulmonol, NL-2300 RC Leiden, Netherlands
[4] Gaubius Lab, TNO Metab Hlth Res, NL-2301 CE Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands
[6] Hannover Med Sch, Inst Clin Pharmacol, D-30625 Hannover, Germany
[7] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands
来源
JOURNAL OF NUTRITIONAL BIOCHEMISTRY | 2013年 / 24卷 / 08期
关键词
Atherosclerosis; Lipids; Oxidative stress; Inflammation; Resveratrol; Statin; LOW-DENSITY-LIPOPROTEIN; TRANS-RESVERATROL; HUMAN MACROPHAGES; OXIDATIVE STRESS; DEFICIENT MICE; RED WINE; EXPRESSION; INFLAMMATION; COMBINATION; ATTENUATION;
D O I
10.1016/j.jnutbio.2012.11.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resveratrol is a major constituent of traditional Asian medicinal herbs and red wine and is suggested to be a potential antiatherosclerotic drug due to its proposed hypolipidemic, anti-inflammatory and antioxidative properties. The aim of this study was to evaluate whether resveratrol protects against atherosclerosis development in APOE*3-Leiden.CETP (E3L.CETP) mice and adds to the antiatherogenic effect of mild statin treatment, currently the most widely used antiatherogenic therapy. E3L.CETP mice were fed a cholesterol-rich diet without (control) or with resveratrol (0.01% w/w), atorvastatin (0.0027% w/w) or both for 14 weeks. During the study plasma lipid, inflammatory and oxidative stress parameters were determined. Resveratrol reduced atherosclerotic lesion area (-52%) in the aortic root, comparable to atorvastatin (-40%) and the combination of both drugs (-47%). The collagen/macrophage ratio in the atherosclerotic lesion, a marker of plaque stability, was increased by resveratrol (+108%), atorvastatin (+124%) and the combination (+154%). Resveratrol decreased plasma cholesterol levels (-19%) comparable to atorvastatin (-19%) and the combination (-22%), which was completely confined to (very)low-density lipoprotein cholesterol levels in all groups. Post hoc analyses showed that the antiatherogenic effect of atorvastatin could be explained by cholesterol lowering, while the antiatherosclerotic effect of resveratrol could be attributed to factors additional to cholesterol lowering. Markers of inflammation and oxidative stress were not different, but resveratrol improved macrophage function. We conclude that resveratrol potently reduces atherosclerosis development and induces a more stable lesion phenotype in E3L.CETP mice. However, under the experimental conditions tested, resveratrol does not add to the antiatherogenic effect of atorvastatin. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1423 / 1430
页数:8
相关论文
共 50 条
  • [1] Resveratrol Protects Against Atherosclerosis Development in APOE☆3-Leiden.CETP Mice
    Berbee, Jimmy F.
    Wong, Man-Chi
    Wang, Yanang
    Van der Hoorn, Jose W.
    Romijn, Johannes A.
    Havekes, Louis M.
    Princen, Hans M.
    Rensen, Patrick C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E42 - E43
  • [2] RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN.CETP MICE
    Berbee, J.
    Wong, M-C
    Wang, Y.
    van der Hoorn, J.
    Romijn, J.
    Havekes, L.
    Princen, H.
    Rensen, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [3] RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN-CETP MICE
    Berbee, J.
    Wong, M. -C.
    Wang, Y.
    van der Hoorn, J.
    Romijn, H.
    Havekes, L.
    Princen, H.
    Rensen, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 22 - 22
  • [4] Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice
    Schilperoort, Maaike
    van den Berg, Rosa
    Coomans, Claudia P.
    Khedoe, Padmini P. S. J.
    Ramkisoensing, Ashna
    Boekestijn, Sanne
    Wang, Yanan
    Berbee, Jimmy F. P.
    Meijer, Johanna H.
    Biermasz, Nienke R.
    Rensen, Patrick C. N.
    Kooijman, Sander
    JOURNAL OF BIOLOGICAL RHYTHMS, 2020, 35 (06) : 598 - 611
  • [5] The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice
    Lisa R. Hoving
    Saeed Katiraei
    Amanda Pronk
    Marieke Heijink
    Kelly K. D. Vonk
    Fatiha Amghar-el Bouazzaoui
    Rosalie Vermeulen
    Lizette Drinkwaard
    Martin Giera
    Vanessa van Harmelen
    Ko Willems van Dijk
    Scientific Reports, 8
  • [6] NIACIN, ATORVASTATIN AND FENOFIBRATE DECREASE PLASMA CETP BY REDUCTION OF THE HEPATIC MACROPHAGE CONTENT IN APOE*3-LEIDEN.CETP MICE
    Wang, Y.
    Li, Z.
    Hoekstra, M.
    Bieghs, V.
    Shiri-Sverdlov, R.
    Van Berkel, T. J. C.
    Smit, J. W. A.
    Princen, H. M. G.
    Romijn, J. A.
    Havekes, L. M.
    Rensen, P. C. N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 38 - 38
  • [7] Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
    de Haan, Willeke
    van der Hoogt, Caroline C.
    Westerterp, Marit
    Hoekstra, Menno
    Dallinga-Thie, Geesje M.
    Princen, Hans M. G.
    Romijn, Johannes A.
    Jukema, J. Wouter
    Havekes, Louis M.
    Rensen, Patrick C. N.
    ATHEROSCLEROSIS, 2008, 197 (01) : 57 - 63
  • [8] Mild Exercise Does Not Prevent Atherosclerosis in APOE*3-Leiden.CETP Mice or Improve Lipoprotein Profile of Men with Obesity
    Panhuis, Wietse In het
    Kooijman, Sander
    Brouwers, Bram
    Verhoeven, Aswin
    Pronk, Amanda C. M.
    Streefland, Trea C. M.
    Giera, Martin
    Schrauwen, Patrick
    Rensen, Patrick C. N.
    Schonke, Milena
    OBESITY, 2020, 28 : S93 - S103
  • [9] THE EFFECT OF ALISKIREN ON ATHEROSCLEROSIS DEVELOPMENT IN APOE*3LEIDEN.CETP TRANSGENIC MICE WITH AND WITHOUT TREATMENT WITH ATORVASTATIN
    Jordaan, S.
    van der Hoorn, J. W. A.
    Havekes, L. M.
    Liau, G.
    Jukema, J. W.
    Princen, H. M. G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 31 - 31
  • [10] The Effect of Aliskiren on Atherosclerosis Development in APOE*3Leiden.CETP Transgenic Mice with and Without Atorvastatin Treatment
    Van der Hoorn, Jose W.
    Jordaan, Susan
    Havekes, Louis M.
    Liau, Gene
    Jukema, J. W.
    Princen, Hans M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E292 - E292